Leukemia stem cells

Annals of Hematology

Volumn 90, Issue 3, 2011, Pages 245-271

  Testa, Ugo ^a  

^a Oncology and Molecular Medicine   (Italy)

Author keywords

Acute leukemia; Leukemia; Myelodysplasia; Myeloproliferative disorders; Stem cells

Indexed keywords

3 BENZYL 7 CYANO 2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 THIENYLSULFONYL) 1H 1,4 BENZODIAZEPINE; ALPHA INTERFERON; ARSENIC TRIOXIDE; BORTEZOMIB; CYCLOPAMINE; CYTARABINE; DASATINIB; GEMTUZUMAB OZOGAMICIN; HISTONE DEACETYLASE INHIBITOR; IMATINIB; LENALIDOMIDE; N TERT BUTYL 3 [5 METHYL 2 [4 (4 METHYL 1 PIPERAZINYL)PHENYLAMINO] 4 PYRIMIDINYLAMINO]BENZENESULFONAMIDE; NILOTINIB; PROTEASOME INHIBITOR; ZILEUTON;

5Q- SYNDROME; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CANCER STEM CELL; CANCER SURVIVAL; CELL HETEROGENEITY; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DISEASE MODEL; DRUG TARGETING; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMIA STEM CELL; LEUKEMOGENESIS; MATHEMATICAL MODEL; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHUMAN; NONOBESE DIABETIC MOUSE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCID MOUSE; SIGNAL TRANSDUCTION; XENOTRANSPLANTATION;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; EPIGENESIS, GENETIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; MICE; MICE, INBRED NOD; MICE, SCID; MOLECULAR TARGETED THERAPY; MUTATION; MYELODYSPLASTIC SYNDROMES; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS;

EID: 79951670098     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1118-7     Document Type: Review

References (199)

1. GC Bosma RP Custer MJ Bosma 1983 A severe combined immunodeficiency mutation in the mouse Nature 301 527 530 1:STN:280:DyaL3s7hsFehsw%3D%3D 6823332 (Pubitemid 13160576)
2. T Tanaka F Kitamura Y Nagasaka K Kuida H Suwa M Miyasaka 1993 Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice J Exp Med 178 1103 1107 1:CAS:528:DyaK3sXlsFyjsr8%3D 8350049 (Pubitemid 23260450)
3. O Kollet A Pelled T Byk 2000 Beta2 microglobulin-deficient (β2m(null)) NOD/SCID mice are excellent recipient for studying human stem cell function Blood 95 3102 3105 1:CAS:528:DC%2BD3cXjt1equ7g%3D 10807775 (Pubitemid 30321160)
4. F Mazurier M Doedens OI Gan JE Dick 2003 Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells Nature Medicine 9 959 963 1:CAS:528: DC%2BD3sXkvFOjs7w%3D 12796774 (Pubitemid 36889941)
5. M Ito H Hiramatsu K Kobayashi 2002 NOD/SCID/gamma null mouse: an excellent recipient mouse model for engraftment of human cells Blood 100 3175 3182 1:CAS:528:DC%2BD38XosVSisLg%3D 12384415 (Pubitemid 35217065)
6. F Notta S Doulatov JE Dick 2010 Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients Blood 115 3704 3707 1:CAS:528:DC%2BC3cXms1egu78%3D 20207983
7. McDermott SP, Eppert K, Lechman E, Doedens M, Dick JE (2010) Comparison of human cord blood engraftment between compromised mouse strains. Blood 116:193-200
8. M Bhatia JC Wang U Kapp D Bonnet JE Dick 1997 Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice Proc Nat Acad Sci USA 94 5320 5325 1:CAS:528:DyaK2sXjtleltLY%3D 9144235 (Pubitemid 27214781)
9. CI Civin G Almeida-Porada MJ Lee J Olweus LW Terstappen ED Zanjiani 1996 Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo Blood 88 4102 4109 1:CAS:528: DyaK28XntlKgtbo%3D 8943843 (Pubitemid 26399154)
10. + cord blood cells transplanted into NOD/SCID mice Proc Natl Acad Sci USA 99 413 418 1:CAS:528:DC%2BD38Xlt1Cktw%3D%3D 11782553 (Pubitemid 34060375)
11. JL McKenzie OI Gan M Doedens JC Wang JE Diock 2006 Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment Nat Immunol 7 1225 1233 1:CAS:528:DC%2BD28XhtV2gsrbP 17013390 (Pubitemid 44594319)
12. - cells assured by intra-bone marrow injection Blood 101 2924 2931 1:CAS:528:DC%2BD3sXjtFCqsb0%3D 12480697 (Pubitemid 36857976)
13. - severe combined immunodeficiency-repopulating cells by intra-bone marrow injection Stem Cells 25 1348 1355 (Pubitemid 47106001)
14. - SCID-repopulating cells using intra-bone marrow injection Leukemia 24 162 168
15. P Benviste C Frelin S Janmohamed M Barbara R Herrington D Hyam N Iscove 2010 Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential Cell Stem Cell 6 48 58
16. B Dykstra D Kent M Bowie L McCoffrey M Hamilton K Lyons SJ Lee R Brinkman C Eaves 2007 Long-term propagation of distinct hematopoietic differentiation programs in vivo Cell Stem Cell 1 218 229 1:CAS:528:DC%2BD2sXhtVSnsrjO 18371352 (Pubitemid 47215588)
17. GA Challen NC Boles SM Chanebers MA Goodell 2010 Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1 Cell Stem Cell 6 265 278 1:CAS:528:DC%2BC3cXlt1Kms7w%3D 20207229
18. Omatsu Y, Sugiyama T, Kohgara H, Kondoh G, Fuji N, Kohno K, Nagasawa T (2010) The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity (in press)
19. HA Himburg GG Muramoto P Daher SK Maedows JL Russell P Doan JT Chi AB Salter WE Lento T Reya NJ Chao JP Chute 2010 Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells Nat Med 16 475 482 1:CAS:528:DC%2BC3cXjvFWjsro%3D 20305662
20. A Mohyeldin T Garzom-Muvdi A Quinones-Hirojsa 2010 Oxygen in stem cell biology: a critical component of the stem cell niche Cell Stem Cell 7 150 161 1:CAS:528:DC%2BC3cXhtVyrt77L 20682444
21. Grassinger J, Haylock DN, Williams B, Olsen GH, Nilsson SK (2010) Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biological potential. Blood 116:3185-3196
22. IG Winkler V Barbier R Wadley A Zannettino S Williams JP Levesque 2010 Positioning of bone marrow hematopoietic and stromal cells relative to blood in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches Blood 116 375 385 1:CAS:528:DC%2BC3cXhtVejt7vI 20393133
23. T Simsek F Kocabas J Zheng RJ DeBernardinis AI Mahmoud EN Olson JW Schneider CC Zhang HA Sadek 2010 The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche Cell Stem Cell 7 380 390 1:CAS:528:DC%2BC3cXhtVyrurbI 20804973
24. K Takubo N Goda W Yamada H Iruchishima E Ikeda Y Kubota H Shima RS Johnson A Hirao M Suematsu T Suda 2010 Regulation of the HIF-1α level is essential for hematopoietic stem cells Cell Stem Cell 7 391 402 1:CAS:528:DC%2BC3cXhtVyrurbJ 20804974
25. KW Orford DT Scadden 2008 Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation Nat Rev Genet 9 115 128 1:CAS:528: DC%2BD1cXnt1egtg%3D%3D 18202695
26. M Mohrin E Bomke D Alexander MR Wan K Barry-Holson M Le Beau CG Morrison E Passegué 2010 Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis Cell Stem Cell 7 174 185 1:CAS:528:DC%2BC3cXhtVyrt77F 20619762
27. H Kawamoto H Wada Y Katsura 2010 A revised scheme for developmental pathways of hematopoietic cells: the myeloid-based model Int Immunol 22 65 70 1:CAS:528:DC%2BC3cXit1Kisrk%3D 20053701
28. S Doulatov F Notta K Eppert LT Nguyen S Ohoshi JE Dick 2010 Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development Nature Immunol 11 585 593 1:CAS:528:DC%2BC3cXntlSjsL8%3D
29. JP Di Santo 2010 A guardian of T cell fate Science 329 44 45 20595605
30. - common lymphoid progenitor stages in two pro-B-cell development pathways Proc Natl Acad Sci USA 107 5925 5930 1:CAS:528:DC%2BC3cXks1Kktrc%3D 20231472
31. T Lapidot C Sirard J Vormoor B Murdoch T Hoang J Caceres-Cortes M Minden B Paterson MA Caligiuri JE Dick 1994 A cell initiating human acute myeloid leukemia after transplantation in SCID mice Nature 367 645 648 1:STN:280:DyaK2c7ltVKrsg%3D%3D 7509044 (Pubitemid 24067706)
32. D Bonnet JE Dick 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nature Med 3 730 737 1:CAS:528:DyaK2sXkt1GrtLY%3D 9212098 (Pubitemid 27298715)
33. LE Ailles B Gerhard H Kawagoe DE Hogge 1999 Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice Blood 94 1761 1772 1:CAS:528:DyaK1MXmtVahs7k%3D 10477702 (Pubitemid 29411327)
34. WJ Rombouts AC Martens RE Ploemacher 2000 Identification of variables determining the engraftment potential of human acute myeloid leukemia in the human NOD/SCID human chimera model Leukemia 14 889 897 1:STN:280: DC%2BD3c3mtVKmug%3D%3D 10803522 (Pubitemid 30235068)
35. KJ Hope L Jin SE Dick 2004 Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity Nature Immunol 5 738 743 1:CAS:528:DC%2BD2cXlt1Wmuro%3D (Pubitemid 39023306)
36. DC Taussig F Miraki-Moud F Anjos-Alsonso DJ Pearce K Allen C Ridler D Lillington D Bonnet 2008 Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells Blood 112 568 575 1:CAS:528:DC%2BD1cXpsVajurg%3D 18523148
37. - fraction Blood 115 1976 1984 1:CAS:528:DC%2BC3cXhtFensbbJ 20053758
38. + cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. Blood 116:3907-3922
39. Oancea C, Ruster B, Henschler R, Puccetti E, Ruthard M (2010) The t(6;9) associated DEK/CAN fusion protein targets a population of long-term repopulating hematopoietic stem cells for leukemogenic transformation. Leukemia 24:1910-1919
40. P Westervelt AA Lane JL Pollock K Oldtather MS Holt DB Simonjic 2003 High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression Blood 102 1857 1865 1:CAS:528:DC%2BD3sXntFaqsrk%3D 12750176 (Pubitemid 37022583)
41. S Wojiski FC Guibal T Kindler BH Lee JL Jesmeck A Fabian DG Gilliland 2009 PML-RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors Leukemia 23 1462 1471 1:CAS:528:DC%2BD1MXpvF2ktbg%3D 19322209
42. FC Guibal M Alberich-Jorda H Hirai A Ebzalidze E Lavantini A Di Ruscio P Zhang B Santana-Lemos D Neuberg A Wagers E Rego DG Tenen 2009 Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia Blood 114 5415 5425 1:CAS:528:DC%2BC3cXhtFaqug%3D%3D 19797526
43. Oancea C, Ruster B, Roos J, Ali Mian A, Micheilis T, Held H, Dubey A, Serve H, Henschler R, Ruthard M (2009) T(15;17)-PML-RAR-induced leukemogenesis: long-term repopulating hematopoietic stem cells as the initial target and more mature progenitors as the potential targets for final leukemic transformation. Blood ASH Meeting Abstracts 114: abstr 3980
44. DJ Pearce D Taussig K Zibara LL Smith C Ridler C Preudhomme BD Young AZ Rohatiner TA Lister D Bonnet 2006 AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML Blood 107 1166 1173 1:CAS:528:DC%2BD28Xht1OntLg%3D 16234360 (Pubitemid 43156319)
45. M Feuring-Buske B Gerhard J Cashman RK Humphries CJ Eaves DE Hogge 2003 Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2 microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors Leukemia 17 760 763 1:CAS:528:DC%2BD3sXis12isbk%3D 12682634 (Pubitemid 36519373)
46. F Ishikawa S Yoshida Y Saito 2007 Chemotherapy-resistant human AML stem cells home to and engraft within the bone marrow endosteal region Nature Biotechnol 25 1315 1321 1:CAS:528:DC%2BD2sXht1Oru7zP (Pubitemid 350076512)
47. PV Sanchez RL Perry JE Sarry DE Perl K Murphy CR Swider A Bagg JK Choi JA Biegel D Danet-Demoyers M Carroll 2009 A robust xenotransplantation model for acute myeloid leukemia Leukemia 23 2109 2117 1:STN:280:DC%2BD1MjltFSrsg%3D%3D 19626050
48. FE Nicolini JD Cshman DE Hogge RK Humphries CJ Eaves 2004 NOD/SCXID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration Leukemia 18 341 347 1:CAS:528:DC%2BD2cXlt1agsw%3D%3D 14628073 (Pubitemid 38240052)
49. Wunderlich M, Chou FS, Link KA, Mirukawa B, Perry RL, Carroll M, Mulloy JC (2010) AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia (in press)
50. T Matsunaga N Takemoto T Sato R Takimoto I Tanaka A Fujimi T Akiyama H Kuroda Y Kawano M Kobune J Kato Y Hirayama S Sakamaki K Kohda K Miyake Y Niitsu 2003 Interaction between leukemic cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia Nature Med 9 1158 1165 1:CAS:528:DC%2BD3sXmvVWgu7c%3D 12897778 (Pubitemid 37173700)
51. DS Krause K Lazarides VH von Adrian RA Van Etten 2006 Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells Nature Med 12 1175 1180 1:CAS:528:DC%2BD28XhtVChsrjK 16998483 (Pubitemid 44527353)
52. L Jin KJ Hope Q Zhai F Smadjia-Joffe JE Dick 2006 Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nature Med 12 1167 1174 16998484 (Pubitemid 44527352)
53. EJ Rombouts B Pavic B Lowenberg RE Ploemacher 2004 Relation between CXCR4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia Blood 104 550 557 1:CAS:528:DC%2BD2cXlvFSmsrc%3D 15054042 (Pubitemid 38900040)
54. AC Spoo M Lubbert WG Wierda JA Burger 2007 CXCR4 is a prognostic marker in acute myelogenous leukemia Blood 109 786 791 1:CAS:528:DC%2BD2sXivVyrsLk%3D 16888090 (Pubitemid 46105982)
55. DA Sipkins X Wie JW Wu JM Runnels D Coté TK Means AD Luster DT Scadden CP Lin 2005 In vivo imaging of specialized bone marrow endothelial microdomains for tumor engraftment Nature 435 969 973 1:CAS:528: DC%2BD2MXltFeltbc%3D 15959517 (Pubitemid 40896324)
56. A Colmone M Amorim AL Pontier S Wang E Jablonski DA Sipkins 2008 Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells Science 322 1861 1865 1:CAS:528: DC%2BD1cXhsFSmtrbI 19095944
57. U Testa R Riccioni S Militi E Coccia E Stellacci P Samoggia R Latagliata G Mariani A Rossini A Battistini F Lo-Coco C Peschle 2002 Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis Blood 100 2980 2988 1:CAS:528:DC%2BD38XotVGhtL8%3D 12351411
58. CT Jordan D Upchurch SJ Szilvassy ML Guzman DS Howard AL Pettigrew T Meyerrose R Rossi B Grimes DA Rizzieri SM Luger GL Phillip 2000 The interleukin-3 receptor alpha is a unique marker for human acute myelogenous leukemia stem cells Leukemia 14 1777 1784 1:CAS:528:DC%2BD3cXnslWgsbY%3D 11021753
59. M Graf K Hecht S Reif R Pelka-Fleischer K Pfister H Schmetzer 2004 Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies Eur J Haematol 72 89 106 1:CAS:528:DC%2BD2cXhslKrsrc%3D 14962246 (Pubitemid 38161157)
60. --stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission Leukemia 21 1700 1707 (Pubitemid 47086760)
61. L Jin EM Lee HS Ramshaw SJ Busflield AG Peoppl L Wilkinson MA Guthridge D Thomas EF Barry A Boyd DP Gering G Vairo AF Lopez JE Dick RB Lock 2009 Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells Cell Stem Cell 5 31 42 1:CAS:528:DC%2BD1MXoslCnsrY%3D 19570512
62. AE Frankel J Ramage M Kiser R Alexander G Kucera MS Miller 2000 Characterization of diphteria fusion proteins targeted to the human interleukin-3 receptor Protein Engineering 13 575 581 1:CAS:528: DC%2BD3cXmvFSntb4%3D 10964987
63. U Testa R Riccioni M Biffoni D Diverio F Lo-Coco R Foà C Peschle AE Frankel 2005 Diphteria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression Blood 106 2527 2529 1:CAS:528:DC%2BD2MXhtVKqt7rP 15928038 (Pubitemid 41510829)
64. X Du M Ho I Pasrtan 2007 New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells J of Immunotherapy 30 607 613 1:CAS:528:DC%2BD2sXotlKht7w%3D (Pubitemid 47229695)
65. R Majeti MP Chao AA Alizadeh WW Pang S Jaiswal KD Gibbs N van Rooijen IL Weissman 2009 CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells Cell 138 286 299 1:CAS:528:DC%2BD1MXhtVSgtr3N 19632179
66. S Jaiswal CH Jamieson WW Pang CY Park MP Chao R Majeti D Traver N van Rooijen IL Weissman 2009 CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis Cell 138 271 285 1:CAS:528:DC%2BD1MXhtVSgtr3M 19632178
67. M Jawad C Seedhouse U Mony M Grundy NH Rimel M Pallis 2010 Analysis of factors that affect in vitro chemosensitivity of leukemic stem and progenitor cells to gentuzumab ozogamicin (Mylotarg) in acute myeloid leukemia Leukemia 24 74 80 1:CAS:528:DC%2BC3cXltleisw%3D%3D 19776761
68. N Hosen C Park N Tatsumi Y Oji H Sugiyama M Gramatzki AM Krensky IL Weissman 2007 CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia Proc Natl Acad Sci USA 104 11008 11013 1:CAS:528: DC%2BD2sXnsV2ks74%3D 17576927 (Pubitemid 47175217)
69. Becker H, Marcucci G, Mahamy K, Radmacher MD, Mrozek K, Margeson D, Whitman SP, Paschka P, Holland KB, Schwind S, Wu YZ, Powell BL, Carter TH, Kolitz J, Wetzler M, Carroll A, Baer M, Moore J, Caliguri M, Larson R, Bloomfield C (2010) Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Blood 116:788-792
70. W Koever X Zhao S Singh C Pardoux J Zhao ML Guzman S Sen S Yonkovich S Liu X Zhan N Tomasevic C Zhou D Gros CT Jordan J Gotlib ED His A Abo 2009 Monoclonal antibodies against IREM-1: potential for targeted therapy of AML Leukemia 23 1587 1597
71. A Van Rhenen A Van Dongen A Kelder E Rombouts N Feller B Moshaver MS Van Walsum S Zweegam GJ Ossenkoppele GJ Schuurhuis 2007 The novel AML stem cell-associated CLL-1 aids in discrimination between normal and leukemic stem cells Blood 110 2659 2666 17609428 (Pubitemid 47523190)
72. B Moshaver A Van Rhenen A Kelder M Van der Pol M Trewijn C Bachas A Westra G Ossenkoppele S Zweegman GJ Schuurhuis 2008 Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia Stem Cells 26 3059 3067 19096043
73. Y Saito N Uchida S Tanaka N Suzuki M Tomizawa-Murosawa Y Najima S Takagi F Ishikawa 2010 Induction of cell-cycle entry eliminates human leukemia stem cells in a mouse model of AML Nature Biotechnol 28 275 281 1:CAS:528: DC%2BC3cXitVWnsLk%3D
74. T Konuma H Oguro A Iwama 2010 Role of the polycomb group proteins in hematopoietic stem cells Develop Growth Differ 52 505 516 1:CAS:528: DC%2BC3cXhtFCgur%2FE
75. J Lessard G Sauvegeau 2003 BMI-1 determines the proliferative capacity of normal and leukemic stem cells Nature 423 255 260 1:CAS:528: DC%2BD3sXjs1yntbg%3D 12714970 (Pubitemid 40852690)
76. + cells impairs self-renewal and induces apoptosis Blood 114 1498 1505 1:CAS:528:DC%2BD1MXhtVyiur3O 19556423
77. R Majeti MW Becker Q Tian T Lee X Yan R Liu JH Chiang L Hool MF Clarke IL Weissman 2009 Dysregulated gene expression networks in human acute myelogenous leukemia stem cells Proc Natl Acad Sci USA 106 3396 3401 1:CAS:528: DC%2BD1MXivF2jsbY%3D 19218430
78. Y Wang A Kristov A Sinha T North W Goessling Z Feng L Zon S Armstrong 2010 The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML Science 327 1650 1653 1:CAS:528:DC%2BC3cXjslaqsLw%3D 20339075
79. OH Yilmaz R Valdez BK Theisen W Guo DO Ferguson H Wu SJ Morrison 2006 PTEN dependence distinguishes hematopoietic stem cells from leukemia-initiating cells Nature 441 475 482 1:CAS:528:DC%2BD28XkvVykurY%3D 16598206 (Pubitemid 44050144)
80. ML Guzman SJ Neering D Upchurch B Grimes DS Howard DA Rizzieri SM Luger CT Jordan 2001 Nuclear factor-KB is constitutively activated in primitive human acute myelogenous leukemia cells Blood 98 2301 2307 1:CAS:528: DC%2BD3MXnslCru74%3D 11588023
81. ML Guzman RM Rossi S Neelakantan X Li CA Corbett DC Hassane MW Becker JM Bennett E Sullivan JL Lachowicz A Vaughan CJ Sweeney W Matthews M Carroll JL Liesveld PA Crooks CT Jordan 2007 An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells Blood 110 4227 4235
82. E Griessinger V Imbert P Lagadec N Gonthier P Dubruil A Romanelli M Draeno JF Peyron 2007 AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells Leukemia 21 877 885 1:CAS:528:DC%2BD2sXksFeltLs%3D 17330097 (Pubitemid 46672062)
83. ML Guzman C Swiderski DS Howard BA Grimes RM Rossi S Szilvassy CT Jordan 2002 Preferential induction of apoptosis for primary human leukemic stem cells Proc Natl Acad Sci USA 99 16220 16225 1:CAS:528:DC%2BD38Xps1ensbg%3D 12451177 (Pubitemid 35462776)
84. ML Guzman RM Rossi L Kamischly X Li D Peterson D Howard CT Jordan 2005 The sequiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells Blood 105 4163 4169 1:CAS:528:DC%2BD2MXks12ju74%3D 15687234 (Pubitemid 40720758)
85. Kim YR, Eom J, Kim SJ, Jeung HK, Cheong JW, Kim JS, Min YH (2010) Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. J Pharmacol Ex Ther (in press)
86. R Riccioni M Senese D Diverio V Riti S Buffolino G Mariani A Boe M Cedrone F Lo-Coco R Foà C Peschle U Testa 2007 M4 and M5 acute myeloid leukemias display a high sensitivity to bortezomib-mediated apoptosis Br J Haematol 139 194 205 1:CAS:528:DC%2BD2sXht1yht7fL 17897295 (Pubitemid 47493077)
87. E Colado S Alvarez-Fernandez P Maiso J Martin-Sanchez MB Vidriales M Garayoa EM Ocio JC Montero A Pandiella JF San Miguel 2008 The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype Haematologica 93 57 66 1:CAS:528:DC%2BD1cXitVOhsrs%3D 18166786 (Pubitemid 351156152)
88. Y Jin Z Lu K Ding J Li X Du C Chen X Sun Y Wu J Zhan J Pan 2010 Antineoplastic mechanisms of nicosolamide in acute myelogenous leukemia stem cells: inactivation of the NF-KB pathway and generation of reactive oxygen species Cancer Res 70 2516 2527 1:CAS:528:DC%2BC3cXjtFygtbc%3D 20215516
89. Fuchs O (2010) Transcription factor NF-KB inhibitors as a single therapeutic agent or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies. Curr Mol Phamacol 3:98-122
90. - deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level Blood 96 2012 2021 1:CAS:528:DC%2BD3cXms1Chsrk%3D 10979941
91. L Nilsson P Eden E Olsson R Mansson I Astrand-Grundstrom B Strombeck K Theilgaard-Monch K Anderson R Hast E Hellstrom-Lindeberg J Samuelsson G Bergh C Nerlov B Johansson M Sigvardsson A Boeg SE Jacobsen 2007 The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes Blood 110 3005 3014 1:CAS:528:DC%2BD2sXht1Smu7%2FJ 17616640 (Pubitemid 350006955)
92. A Pellagatti M Cazzola A Giagounidis J Perry L Malcovati MG Della Porta M Jadersten S Killick A Verma CJ Norbury E Hellstrom-Lindeberg JS Wainscoat J Boultwood 2010 Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells Leukemia 24 756 764 1:CAS:528:DC%2BC3cXks1Kmu7g%3D 20220779
93. R Tehranchi PS Woll K Anderson N Buza-Vidas T Mizukami AJ Mead I Astrand-Grundstrom B Strombeck A Horvat H Ferry RS Dhanda R Hast T Ryden P Vyas G Gohring B Sclegelberger B Johansson E Hellsstrom-Lindeberg A List L Nilsson SE Jacobsen 2010 Persistent malignant stem cells in del(5q) myelodysplasia in remission N Engl J Med 363 1025 1037 1:CAS:528:DC%2BC3cXhtFKqtb3L 20825315
94. + hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8 Blood 100 259 267 1:CAS:528:DC%2BD38XltF2rtrw%3D 12070035 (Pubitemid 35177455)
95. - bone marrow cells in myelodysplastic syndromes Cytometry 77A 840 848
96. E Thanopoulou J Cashman T Kakagianne A Eaves N Zoumbos C Eaves 2004 Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome Blood 103 4285 4293 1:CAS:528:DC%2BD2cXkvVyitLk%3D 14962905 (Pubitemid 38685375)
97. DM Kerbauy V Lesnikov B Torok-Storb E Bryant HJ Deeg 2004 Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2- microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells Blood 104 2202 2203 1:CAS:528: DC%2BD2cXotVyjsro%3D 15377576 (Pubitemid 39297881)
98. MG Martin JS Welch GL Uy TA Fehniger S Kulkarni EJ Duncavage MJ Walter 2010 Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice Leukemia 24 1662 1664 1:STN:280: DC%2BC3cfhtVentw%3D%3D 20668474
99. C Cobaleda N Gutierrez-Cianca J Perez-Losada T Flores R Garcia-Sauz M Gonzales 2000 A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia Blood 95 1007 1013 1:CAS:528:DC%2BD3cXotV2nsg%3D%3D 10648416 (Pubitemid 30062725)
100. A Castor L Nilsson I Astrand-Grundstrom M Buitenhuis C Ramirez K Anderson 2005 Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia Nat Med 11 630 637 1:CAS:528:DC%2BD2MXkslOksLY%3D 15908956 (Pubitemid 40868303)
101. D Hong R Gupta P Ancliff A Atzberger J Brown S Soneji J Green S Colman W Piacibello V Buckle S Tsuzuki M Greaves T Enver 2008 Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia Science 319 336 339 1:CAS:528:DC%2BD1cXmt1yjtw%3D%3D 18202291
102. CV Cox P Diamanti RS Evely PR Kearns A Blair 2009 Expression of CD133 on leukemia-initiating cells in childhood leukemia Blood 113 3287 3296 1:CAS:528:DC%2BD1MXksFWqsbY%3D 19147788
103. CV Cox RS Evely A Oakhill DH Pamphilon NJ Goulden A Blair 2004 Characterization of acute lymphoblastic progenitor cells Blood 104 2919 2925 1:CAS:528:DC%2BD2cXhtVagu73J 15242869 (Pubitemid 39434980)
104. C Le Viseur M Hotfilder S Bomken K Wilson S Rottgers A Scrauder 2008 In childhood acute lymphoblastic leukemia blasts at different stages of immunophenotypic maturation have stem cell properties Cancer Cell 14 47 58 18598943 (Pubitemid 351885495)
105. S Morisot AS Wayne O Bohana-Kashtan IM Kaplan R Hildreth P Brown 2008 Leukemia stem cells (LSCs) are frequent in childhood precursor B acute lymphoblastic leukemia (ALL) Blood 112 1354 1360
106. HJ Vormoor 2009 Malignant stem cells in childhood acute lymphoblastic leukemia: the stem cell concept revisited Cell Cycle 28 8 11
107. + cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL Leukemia 22 1207 1213 1:CAS:528:DC%2BD1cXntVCjtbc%3D 18418410 (Pubitemid 351833789)
108. - cells Cancer Res 65 1442 1449 1:CAS:528: DC%2BD2MXhsFKqtL4%3D 15735032 (Pubitemid 40270173)
109. MF Greaves J Wiemels 2003 Origins of chromosome translocations in childhood leukemia Nature Rev Cancer 3 639 649 1:CAS:528:DC%2BD3sXmvVWlurc%3D (Pubitemid 37328819)
110. AM Ford C Palmi C Bueno D Hong P Cordes D Knight G Cazzaniga T Ener M Greaves 2009 The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells J Clin Invet 119 826 836 1:CAS:528:DC%2BD1MXktlSntrk%3D
111. + acute leukemia harbor and express the MLL-AF4 fusion gene J Exp Med 206 3131 3141 1:CAS:528:DC%2BD1MXhs1WlsbvN 19995953
112. CG Lullinghan S Goorha I Radtke CB Miller E Coustan-Smith JD Dalton K Girtman S Mathew J Mia SB Pounds X Su CH Pul MV Relling WE Evans SA Shurtleff JR Downing 2007 Genome-wide variation analysis of genetic alterations in acute lymphoblastic leukemia Nature 446 758 764 (Pubitemid 46582031)
113. CM Bateman SM Colman T Chaplin BD Young TO Eden M Bhakta EJ Gratias ER Van Wering G Cazzaniga CJ Harrison R Hain P Anciff AM Ford L Kearney M Greaves 2010 Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia Blood 115 3553 3558 1:CAS:528: DC%2BC3cXmtFyluro%3D 20061556
114. Greaves M (2009) Darwin and evolutionary tales in leukemia. Hematology :3-12
115. M Greaves 2010 Cancer stem cells: back to Darwin? Semin Cancer Biol 20 65 70 20359535
116. AM Ford C Palmi C Bueno D Hong P Cordas D Knight G Cazzaniga T Ener M Greaves 2009 The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells J Clin Invest 119 826 836 1:CAS:528:DC%2BD1MXktlSntrk%3D 19287094
117. C Cox HM Martin PR Kearns P Virgo RS Evely A Blair 2007 Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia Blood 109 674 682 1:CAS:528:DC%2BD2sXivVyrs7o%3D 17003368 (Pubitemid 46105969)
118. W Guo JL Lasky CJ Chang S Mosessian X Lewis Y Xiao JE Yeh ML Iruela-ARispe M Varella-Garcia H Wu 2008 Multi-genetic events collaboratively contribute to PTEN-null leukemia stem-cell formation Nature 453 529 535 1:CAS:528:DC%2BD1cXmt1Ortb8%3D 18463637
119. MP McCormack LF Young S Vasudevan CA De Graaf R Codrington TH Rabbitts SM Jane DJ Curtis 2010 The LMO2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal Science 327 879 883 1:CAS:528:DC%2BC3cXhslWis7k%3D 20093438
120. M Tremblay C Tremblay S Herblot PD Aplan J Hébert C Perreault T Hoang 2010 Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes Genes Dev 24 1093 1105 1:CAS:528:DC%2BC3cXnsV2jtL4%3D 20516195
121. E Coustan-Smith CG Mullighan M Onciu FG Behm S Raimondi D Pei C Cheng X Su JE Rubnitz G Basso A Boindi CH Pui JR Downing D Campana 2009 Early T-cell precursor leukemia: a subtype of very high-risk acute lymphoblastic leukemia Lancet oncology 10 147 156 1:CAS:528:DC%2BD1MXhtlGlu74%3D 19147408
122. JJ Belkl A Bhandoola 2008 The earliest thymic progenitors for T-cell possess myeloid lineage potential Nature 452 764 767 (Pubitemid 351521083)
123. H Wada K Masuda R Satoh 2008 T-cell progenitors retain myeloid potential Nature 452 768 772 1:CAS:528:DC%2BD1cXksFSisrg%3D 18401412 (Pubitemid 351521082)
124. MY Chiang O Shestova G Histen S L'Heureux C Romany ME Childs PA Gimotty JC Aster WS Pear 2008 Leukemia-associated NTCH1 alleles are weak tumor initiators but accelerates K-Ras-initiated leukemia J Clin Invet 118 3181 3194 1:CAS:528:DC%2BD1cXhtV2isbvE
125. R Moellering M Cornejo T Davis C Del Bianco J Aster S Blalow A Kung G Gilliland G Verdine J Bradner 2009 Direct inhibition of the NOTCH transcription factor complex Nature 462 182 188 1:CAS:528:DC%2BD1MXhsVSjsr3F 19907488
126. Y Wu C Cain-Hom TJ Hagenbeek G De Leon Y Chen D Finkle 2010 Therapeutic antibody targeting of individual NOTCH receptors Nature 464 1052 1057 1:CAS:528:DC%2BC3cXkslarur8%3D 20393564
127. T Holyoake X Jiang C Eaves A Eaves 1999 Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia Blood 94 2056 2064 1:CAS:528:DyaK1MXlvFCmsrg%3D 10477735 (Pubitemid 29430422)
128. W Eisterer X Jiang O Christ H Glimm E Pang K Lambie G Shaw TL Holyake AL Petzer C Auewarakul MJ Barnett CJ Eaves AC Eaves 2005 Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease Leukemia 19 435 441 1:STN:280: DC%2BD2M%2FpvVGltA%3D%3D 15674418 (Pubitemid 40403322)
129. + human hemopoietic cells from normal and chronic myeloid leukemia sources Stem Cells 25 3111 3120 1:CAS:528:DC%2BD1cXnvFCluw%3D%3D 17717066 (Pubitemid 350294437)
130. HG Jorgensen TL Holyoake 2007 Characterization of cancer stem cells in chronic myeloid leukemia Biochem Soc Trans 45 pt5 730 737
131. + leukemia in mice Proc Natl Acad Sci USA 103 16870 16875 1:CAS:528:DC%2BD28Xht1egurvM 17077147 (Pubitemid 44737345)
132. CH Jamieson LE Ailles SJ Dylla 2004 Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N Engl J Med 351 657 667 1:CAS:528:DC%2BD2cXms1Oktbg%3D 15306667 (Pubitemid 39063268)
133. Y Minami SA Stuart T Ikawa Y Jiang A Banno IC Hunton 2008 BCR-transformed GMP as myeloid leukemic stem cells Proc Natl Acad Sci USA 105 17967 17972 1:CAS:528:DC%2BD1cXhsVCmu7zO 19004799
134. - cell population with intrinsic resistance to imatinib Blood 114 5191 5200 1:CAS:528:DC%2BC3cXls1arug%3D%3D 19855080
135. Jaras M, Johnels P, Hansen N, Agerstam H, Tsapogas P, Rissler M, Lassen C, Olofsson T, Bjerrum OW, Richter J, Fioretos T (2010) Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc Natl Acad Sci USA 107:16820-16825
136. SM Graham HG Jorgensen E Allan C Pearson MJ Alcorn L Richmond TL Holyoake 2002 Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro Blood 99 319 325 1:CAS:528:DC%2BD38XivF2gug%3D%3D 11756187
137. M Copland A Hamilton LJ Elrick JW Baird EK Allan N Jordanides M Barow JC Mountford TL Holyoake 2006 Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction Blood 107 4532 4539 1:CAS:528:DC%2BD28Xlt1CgtrY%3D 16469872 (Pubitemid 43801382)
138. + CML cells Blood 109 4016 4019 1:CAS:528:DC%2BD2sXkvFCiurc%3D 17213283 (Pubitemid 46641755)
139. F Michor TP Hughes Y Iwasa 2005 Dynamics of chronic myeloid leukemia Nature 435 1267 1270 1:CAS:528:DC%2BD2MXls1Ontbo%3D 15988530
140. X Jiang Y Zhao C Smith M Gasparetto A Turhan A Eaves C Eaves 2007 Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies Leukemia 21 926 935 1:CAS:528:DC%2BD2sXksFeltL4%3D 17330101 (Pubitemid 46672068)
141. + CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate. Blood 116:2112-2121
142. Y Hu Y Chen L Douglas S Li 2009 Beta-catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia Leukemia 23 109 116 1:CAS:528:DC%2BD1MXkvVaquw%3D%3D 18818703
143. C Zhao J Blum A Chan HY Zwon SH Jung JM Cook 2007 Loss of beta-catenin supports the renewal of normal and CML stem cells in vivo Cancer Cell 12 528 541 1:CAS:528:DC%2BD2sXhsVGmu73P 18068630 (Pubitemid 350199070)
144. C Peng Y Chen Z Yang H Zhang L Osterby AG Rosmarin S Li 2010 PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice Blood 115 626 635 1:CAS:528:DC%2BC3cXhsFegsb4%3D 19965668
145. M Sobrinho-Simoes V Wilczek J Score N Cross J Apperley J Melo 2010 In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib Blood 116 1329 1335 1:CAS:528:DC%2BC3cXhtFersbbE 20462961
146. S Koschmieder B Gottgens P Zhang J Iwasaki-Arai K Akashi JL Kutok T Dayaram K Geary AR Green DG Tenen CS Huettner 2005 Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis Blood 105 324 334 1:CAS:528: DC%2BD2MXis1Kjuw%3D%3D 15331442 (Pubitemid 40053100)
147. M Schemionek C Elling U Steidl N Baumer A Hamilton T Spieker JR Gothert M Stehling A Wagers CS Huettner DG Tenen L Tickenbrock WE Berdel H Serve TL Hoylake C Muller-Tidow S Koschmieder 2010 BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells Blood 115 3185 3195 1:CAS:528:DC%2BC3cXlvVags74%3D 20053753
148. K Naka T Hoshii T Maraguchi Y Tadokoro T Ooshio Y Kondo S Nakao N Motoyama A Hirao 2010 TGF-β-FOXO signaling maintains leukemia-initiating cells in chronic myeloid leukemia Nature 463 676 680 1:CAS:528: DC%2BC3cXhsVygtL4%3D 20130650
149. C Dierks R Beigi GR Guo K Zirlik P Manley 2008 Expansion of BCR-ABL-positive leukemic stem cells is dependent on Hedgehog pathway activation Cancer Cell 14 238 249 1:CAS:528:DC%2BD1cXhtFKnu73J 18772113
150. C Zhao A Chen CH Jamieson M Fereshteh A Abrahansson J Blun HY Kwon J Kim JP Chute D Rizzieri M Monchof T VanArsdal PA Beachy AT Key 2009 Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukemia Nature 458 776 779 1:CAS:528:DC%2BD1MXht1egsrY%3D 19169242
151. I Hofmann EH Stover DE Cullen J Mao KJ Morgan BH Lee MG Kharas PG Miller MG Cornejo R Okabe SA Armstrong N Ghilardi S Gould FJ De Sauvage AP McMahon DG Gilliland 2009 Hedgehog signaling is dispensable for adult murine hetopoietic stem cell function and hematopoiesis Cell Stem Cell 4 559 567 1:CAS:528:DC%2BD1MXnt1Ggtbo%3D 19497284
152. Y Chen Y Hu H Zhang C Peng S Li 2009 Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia Nature Genetics 41 783 792 1:CAS:528:DC%2BD1MXntVWit7s%3D 19503090
153. + human hemopoietic cells from normal and chronic myeloid leukemia sources Stem Cells 25 3111 3120 1:CAS:528:DC%2BD1cXnvFCluw%3D%3D 17717066 (Pubitemid 350294437)
154. K Ito R Bernardi A Morotti S Matsuoka G Saglio Y Ikeda J Rosenblatt DE Avigan J Teruya-Fedelstein PP Pandolfi 2008 PML targeting eradicates quiescent leukemia-initiating cells Nature 453 1072 1078 1:CAS:528:DC%2BD1cXntlGjtb0%3D 18469801 (Pubitemid 351871736)
155. + human leukemias of AHI-1, a gene activated by insertional mutagenesis in mouse models of leukemia Blood 103 3897 3904 1:CAS:528:DC%2BD2cXjvF2hsr8%3D 14751929 (Pubitemid 38596311)
156. LL Zhou Y Zhao A Ringrose D DeGeer E Kennah A Lin G Sheng XJ Li A Turhan X Jiang 2008 AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells J Exp Med 205 2557 2671
157. D DeGeer K Newmarch L Zhou M Chen MS Saw AG Turhan X Jiang 2009 A novel AHI-1-BCR-ABL-JAK2 interaction complex mediates cellular resistance to tyrosine kinase inhibitors in CML ASH Annual Meeting Abstracts 114 38
158. W Fiskus M Pronpat M Balasis P Bali V Estrella S Kamaraswamy R Rao K Rocha B Herger F Lee 2006 Cotreatment with varinostat enhances activity of desatinib against imatinib mesylate-sensitive or imatinib mesylate-resistant chronic myelogenous leukemia cells Cancer Res 12 5869 5878 1:CAS:528: DC%2BD28XhtVartbnM (Pubitemid 44629620)
159. B Zhang AC Strauss S Chu Y Ho KD Shiang DS Snyder CS Huettner L Shultz T Holyoake R Bhalia 2010 Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate Cancer Cell 17 427 442 20478526
160. MA Essers S Offner WE Balnco-Bose 2009 IFNα activates dormant hematopoietic stem cells in vivo Nature 458 904 908 1:CAS:528: DC%2BD1MXhvFKjtLg%3D 19212321
161. T Sato N Onai H Yoshihara 2009 Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion Nature Med 15 696 700 1:CAS:528:DC%2BD1MXms1aktLg%3D 19483695
162. P Rousselot F Huguet D Rea L Legros JM Cayuela O Maarek 2007 Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years Blood 109 58 60 1:CAS:528:DC%2BD2sXivVyrtL4%3D 16973963 (Pubitemid 46053043)
163. + leukemic cells acquiring stem-like characteristics in a hypoxic environment Cell Death Diff 17 1211 1220 1:CAS:528:DC%2BC3cXnsVOgurk%3D
164. F Servida D Soligo D Derlia C Henderson C Brancolini L Lombardi GL Deliliers 2005 Sensitivity of human multiple myelomas and myeloid leukemias to the proteasome inhibitor I Leukemia 19 2324 2331 1:CAS:528:DC%2BD2MXht1emsL7M 16224484 (Pubitemid 41741629)
165. NB Heaney F Pellicano B Zhang L Crawford S Chu SM Kazmi EK Allan HG Jorgensen AE Irvine R Bhatia TL Hloyoake 2010 Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells Blood 115 2241 2250 1:CAS:528:DC%2BC3cXktVSltr4%3D 20068223
166. M Copland F Pellicano L Richmond EK Allan A Hamilton FY Lee R Weinmann TL Holyoake 2008 BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors Blood 111 2843 2853 1:CAS:528:DC%2BD1cXivFakurg%3D 18156496
167. - cells, through activation of protein kinase Cbeta Blood 114 4186 4196 1:CAS:528:DC%2BD1MXhsVGku7jN 19738029
168. C Bellodo MR Lidonnici A Hamilton GV Helagson AR Soliera M Ronchetti S Galavotti KW Young T Selmi R Yacobi RA Van Etten N Donato A Hunter E Tirrò P Vigneri P Nicotera MJ Dyer T Holyoake P Salomoni B Calabretta 2009 Targeting autophagy potentiates tyrosine inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells J Clin Invest 119 1109 1123
169. C James V Ugo JP Le Couédic J Staerk F Delhommeau C Lacout L Garcon H Raslova R Berger A Bennaceur-Griscelli JL Villeval SN Constantinescu N Casadevall W Vainchenker 2005 A unique clonal JAK2 mutation leading to constitutive signaling causes polythemia vera Nature 434 1144 1148 1:CAS:528:DC%2BD2MXjsF2ltbk%3D 15793561 (Pubitemid 40663494)
170. CH Jamieson J Gotlib JA Durocher MP Chao MR Mariappan C Jones JL Zehnder SL Lilleberg IL Weissman 2006 The JAK2 V617F mutation occurs in hematopoietic cells in polycythemia vera and predisposes toward erythroid differentiation Proc Nat Acad Sci USA 103 6224 6229 1:CAS:528:DC%2BD28XktFamsL8%3D 16603627
171. F Delhommeau S Dupont C Tonetti A Massé I Godin JP Le Couedic N Debili P Saulnier N Casadevall W Vainchenker S Giraudier 2007 Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis Blood 109 71 77 1:CAS:528:DC%2BD2sXivVyrtL0%3D 16954506 (Pubitemid 46053046)
172. C James F Mazurier S Dupont R Chaligne I Lamrissi-Garcia M Tulliez E Lippert FX Mahon JM Pasquet G Etienne F Delhommeau S Giraidier W Vainchenker H De Verneuil 2008 The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders in a reflection of disease heterogeneity Blood 112 2429 2438 1:CAS:528:DC%2BD1cXhtFCru77E 18612101
173. A Mulally S Lane B Ball C Megerdichian R Okabe F Al-Shahrour M Paktinant JE Haydu E Housman A Lord G Wernig M Kharas T Mercher J Kotok G Gilliland B Ebert 2010 Physiological JAK2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells Cancer Cell 17 584 596
174. Li J, Spensberger D, Ahn JS, Anand S, Beer PA, Ghevaert C, Chen E, Forrai A, Scott LM, Ferreira R, Campbell PJ, Watson SP, Liu P, Erber WN, Huntly BJ, Ottersbach K, Green AR (2010) JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood 116:1528-1538
175. H Akada D Yan H Zou S Fiering RE Hutchison MG Mohi 2010 Conditional expression of heterozygous or homozygous JAK2V617F from its endogenous promoter induces polycythemia vera-like disease Blood 115 3589 3597 1:CAS:528: DC%2BC3cXmtFylurY%3D 20197548
176. V617F in knock-in mice Blood 116 783 787 1:CAS:528: DC%2BC3cXhtVCku73M 20472827
177. F Delhommeau S Dupont V Della Valle C James S Trannoy A Massé O Kosmider JP Le Couedic F Robert A Alberdi Y Lécluse I Plo FJ Dreyfus C Marzac N Casadevall C Lacombe SP Romana P Dessen J Soulier F Viguié M Fontenay W Vainchenker OA Bernard 2009 Mutation in TET2 in myeloid cancers N Engl J Med 360 2289 2301 19474426
178. S Ito A D'Alessio O Taranova K Hong L Sowers Y Zhang 2010 Role of Tet proteins in 5mC to 5hm conversion, ES-cell self-renewal and inner mass specification Nature 466 1129 1133 1:CAS:528:DC%2BC3cXovFCntro%3D 20639862
179. H Haeno RL Levine G Gilliland F Michor 2009 A progenitor cell origin of myeloid malignancies Proc Natl Acad Sci USA 106 16616 16621 1:CAS:528: DC%2BD1MXht1Ogs77E 19805346
180. F Schaub R Losser S Li H Hao-Schen T Lehmann A Tichelli RC Skoda 2010 Clonal analysis of TET2 and JAK2 mutations suggest that TET2 can be a late event in the progression of myeloproliferative neoplasms Blood 115 2003 2007 1:CAS:528:DC%2BC3cXhtFensbbE 20061559
181. A Teffeeri 2010 Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, AXL1, CBL, IDH and IKZF1 Leukemia 24 1128 1138
182. AV Jones A Chase RT Silver D Oscier K Zoi YL Wang H Carlo HL Pahl A Collins A Reityer F Grand NC Cross 2009 JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms Nature Genet 41 446 449 1:CAS:528:DC%2BD1MXjtFCis7c%3D 19287382
183. D Olcaydu A Harutyunyan R Jager T Berg B Gisslinger I Pabinger H Gisslinger R Kralovics 2009 A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms Nature Genet 41 450 454 1:CAS:528: DC%2BD1MXjtFCisb4%3D 19287385
184. O Kilpivaara S Mukherjee AM Schram M Wadleigh A Mulally BL Ebert A Bass S Marubayashi A Heguy G Garcia-Manero H Kantarjian K Offitt RM Stone DG Gilliland RJ Klein RL Levine 2009 A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms Nature Genet 41 455 459 1:CAS:528:DC%2BD1MXjtFCisLw%3D 19287384
185. PJ Campbell 2009 Somatic and germile genetics at the JAK2 locus Nature Genet 41 385 386 1:CAS:528:DC%2BD1MXjslartLs%3D 19338077
186. A Jones PJ Campbell P Beer S Schnittger A Vannucchi K Zoi M Percy MF McMullin L Scott W Tapper R Silver D Oscier C Harrison H Grallert A Kisialiou P Strike A Chase A Green N Cross 2010 The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms Blood 115 4517 4523 1:CAS:528:DC%2BC3cXnsFKntLg%3D 20304805
187. P Beer F Delhommeau JP Le Couédic M Dawson E Chen D Bareford R Kusec F McMullin C Harrison A Vannucchi W Vainchenker A Green 2010 Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm Blood 115 2891 2900 1:CAS:528:DC%2BC3cXkvFKhsro%3D 20008300
188. Z Ye H Zhan P Mali S Dowey DM Williams YY Jang CV Dang JL Spivak AR Moliterno L Cheng 2009 Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood 114 5473 5480 1:CAS:528:DC%2BC3cXhtFejtg%3D%3D 19797525
189. J Dick 2008 Stem cell concepts renew cancer research Blood 112 4793 4807 1:CAS:528:DC%2BD1cXhsFWmtr3M 19064739
190. A Cozzio E Passegué PM Ayton H Karsunky ML Cleary IL Weismann 2003 Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors Genes Dev 17 3029 3035 1:CAS:528: DC%2BD2cXhs1ShsQ%3D%3D 14701873 (Pubitemid 38040767)
191. E Passegué CHM Jamieson SLE Aille IL Weissman 2003 Normal and leukemic hemopoiesis: are leukemias a stem cell disorder or reacquisition of stem cell characteristics? Proc Natl Acad Sci USA 100 11842 11849 14504387 (Pubitemid 37205893)
192. BJ Huntly H Shigematsu K Deguchi BH Lee S Mizuno N Duclos R Rowan S Amarel D Curley IR Cliams 2004 MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors Cancer Cell 6 587 596 1:CAS:528:DC%2BD2MXktVanug%3D%3D 15607963 (Pubitemid 40017702)
193. AV Krivtsov D Twomey Z Feng MC Stubbs Y Wang J Faber JE Levine J Wang WC Hahn DG Gilliland 2006 Transformation from committed progenitor to leukemia stem cell initiated by MLL-AF9 Nature 442 818 822 1:CAS:528:DC%2BD28XotFKmtr0%3D 16862118 (Pubitemid 44258912)
194. TC Sommervaille CJ Matheny CJ Spenver M Iwasaki JL Rinn DM Witten HY Chang A Shurtleffs JR Downing ML Cleary 2009 Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells Stem Cells 4 129 140
195. O Bereshchenko E Mancini S Moore D Bilbao R Mansson S Luc A Grover SW Jacobsen D Bryder C Nerlov 2009 Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML Cancer Cell 16 390 400 1:CAS:528:DC%2BD1MXhsFKltb3M 19878871
196. T Miyamoto IL Weissman K Akashi 2000 AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8:21 chromosomal translocation Proc Natl Acad Sci USA 97 7521 7526 1:CAS:528:DC%2BD3cXksVKhs7c%3D 10861016 (Pubitemid 30431496)
197. Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hidreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI (2010) High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia 24:1859-1866
198. Chiu PP, Jiang H, Dick JE (2010) Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance. Blood (in press)
199. M Raaijmakers S Mukherjee S Guo S Zhang T Kobayashi J Scoonmaker B Ebert F Al-Shahrour R Hasserjian EO Scadden Z Aung M Matza M Merkenschlager C Lin JM Rommens DT Scadden 2010 Bone progenitor dysfunction induces myelodysplasia and secondary leukemia Nature 464 852 857 1:CAS:528:DC%2BC3cXjs1egsr0%3D 20305640